The serum CK 19 fragment (CYFRA 21-1) stands out as a circulating marker in dedifferentiated thyroid cancers such as anaplastic thyroid carcinoma and poorly differentiated carcinoma [36,37]. Here, KRT19 is linked to thyroid cancer.